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Abstract 
Objective: To evaluate the relationship between the mRNA transcription level of Matrix 
Metalloproteinase-9 (MMP-9) and the selected clinical periodontal healing at one month of 
scaling and root planing. Material and Methods: A total of six chronic periodontitis patients 
and one periodontally healthy subject were recruited. The gingival crevicular fluid was collected 
from all subjects, and the expression level of MMP-9 mRNA was measured by quantitative real-
time PCR. Pocket depth, papilla bleeding index, and clinical attachment loss were measured on 
day 1 at baseline and day 30. Scaling and root planing was performed on day 1. Data were 
analyzed using SPSS 22.0 software. Results: In comparison to the control, periodontal clinical 
parameters in the treatment group were significantly reduced after scaling and root planing. 
MMP-9 mRNA expression did not show a significant change after the 30th day. A weak 
correlation was noted between the MMP-9 mRNA transcription level and the changed PBI 
measurement. Conclusion: Scaling and root planing is clinically effective for chronic 
periodontitis with a 4-6 mm pocket, whereas the expression of MMP-9 mRNA was not altered. 
Further studies with a more extended observation period are needed to confirm or reject the 
present findings. 
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Introduction 
Periodontal diseases have a high prevalence, affecting 20-50% of the global population, and it 
is one of the major causes of tooth loss in adults [1]. Interaction of bacteria plaque with host 
response triggers inflammation, which leads to periodontal attachment loss and bone destruction 
[3,4]. 
The tissue breakdown events that lead to the clinical signs of disease are a result of the host 
inflammatory response to the bacterial plaque [5]. Matrix metalloproteinases (MMPs) are involved 
in the physiological degradation of extracellular matrix proteins and basement membranes. They are 
considered mediators of tissue destruction and are strongly correlated with the occurrence of 
periodontal diseases. MMP-9, also known as gelatinase B, degrades type-IV collagen and regulates 
basement membrane remodeling. MMP-9 is expressed by polymorphonuclear leukocytes, 
macrophages, and epithelial cells, which reflect periodontal disease severity, progression, and 
treatment response [3,4,6]. MMP-9 level increases in the gingival crevicular fluid (GCF) of sites 
with active periodontal diseases [7,8]. 
Non-surgical therapy is known to successfully arrest periodontitis progression in shallow to 
moderate pockets. The goal of non-surgical treatment is to eliminate or reduce pathogens (shifting 
microbial flora) to create a favorable environment, which will stabilize periodontal conditions 
achieved by scaling and root planing (SRP), dental health education, and patient motivation [9]. 
We hypothesized that the mRNA expression of MMP-9 in GCF decreases following SRP 
performed on CP patients with a pocket depth (PD) of 4-6 mm. Therefore, the present study aimed 
to assess the effect of scaling and root planing on the mRNA expression of MMP-9 in gingival 
crevicular fluid over one month as well as to evaluate its correlation with the clinical parameters of 
the healing progress of the periodontal tissues. 
 
Material and Methods 
Subject Selection 
The study was conducted from March 2018 to June 2018 at the Periodontic Clinic Faculty of 
Dentistry, Universitas Indonesia. The study included six chronic periodontitis patients and one 
healthy subject. The inclusion criteria were chronic periodontitis patients of age 35-55 years with 4 
to 6 mm pockets, loss of clinical attachment ≥2 mm, bleeding on probing, and exclusion of the third 
molar. The exclusion criteria were patients with systemic diseases, smokers, patients who had 
undergone a periodontal treatment in the past six months, pregnant or breastfeeding patients, 
patients using contraceptives, and patients who have taken antibiotics in the last three months. 
The healthy periodontal subject exhibited a probing depth of <3 mm, no bleeding on 
probing, and no clinical attachment loss. The subjects signed an informed consent form after 
receiving information about this study. Data collected during the first visit were followed by SRP 
using an ultrasonic instrument and collected again after one month. 
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Clinical Assessment 
Periodontal clinical parameters consist of Pocket Depth (PD), Papilla Bleeding Index (PBI), 
and Clinical Attachment Loss (CAL). The parameters were measured on six sides of each tooth (i.e., 
mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, and disto-lingual) using a 
periodontal probe instrument UNC-15 (MND Co. Ltd, Seoul, Korea). PD is the distance (in 
millimeters) from the free gingival margin to the base of the pocket. PBI is measured by carefully 
inserting a periodontal probe into the margin of the gingival sulcus and scored as follows: 0 =no 
bleeding; 1 = bleeding in the form of a point; 2 = bleeding in the form of a line; 3 = bleeding in the 
form of a triangle; and 4 = widespread bleeding. CAL is the distance (in millimeters) from the border 
of the cemento-enamel junction to the base of the pocket. 
 
GCF Collection and RNA Extraction 
Teeth were isolated using a cotton roll, followed by the removal of the supragingival plaque 
to avoid GCF contamination. Then, the crevicular site was gently dried with air syringe, followed by 
inserting three paper points (number 20) into the deepest pocket site for 20 s. The paper points were 
further placed into a microcentrifuge tube containing 1 mL of sterile TE buffer in an icebox. All 
clinical samples were immediately transferred to a laboratory for in vitro processing. In this study, 
RNA extraction and transcription to cDNA were performed using a Toyobo kit. All procedures were 
performed in accordance with the instructions provided by the company. For RT-PCR reaction, the 
final volume was 10 µL per microtube, which contained 3 µL of cDNA, 0.5 µLeach of forward and 
reverse primers, 5 µL of the SensiFAST SYBR® Hi-ROX Kit, and 1 µL of nuclease-free water. The 
amplification cycling conditions were initial denaturation at 95°C for 10 min, followed by 40 cycles 
of annealing at 60°C for 60s and an extension at 72°C for 30 s [10]. All samples were run in 
duplicate in the MicroAmp™ Fast Optical 48-well Plates in Applied Biosystems StepOne Plus 
(Applied Biosystems Inc., Foster City, CA, USA). The primers used in the amplification phase were 
MMP-9 primers (forward 5′-GGG ACG CAG ACA TCG TCA TC-3′ and reverse 5′-TCG TCA 
TCG TCG AAA TGG GC-3′). The primers for human glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) were used to normalize the mRNA expression of MMP-9. The primer sequences of 
GAPDH consisted of forwarding primer 5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse primer 
5′-GAAGATGGTGATGGGATTTC-3′ [11], and the PCR cycling conditions were as follows: 
initial denaturation at 95°C for 10 min, followed by 40 cycles at 94°C for 30 s, at 55°C for 30 s, and 
at 72°C for 30 s. The formula used to calculate the difference in the expression of mRNA MMP-9 
between the two groups (before and after treatment) was 2-ΔΔ Ct. 
 
Statistical Analysis 
Statistical analysis was performed using the IBM SPSS Statistics Software, version 22 (IBM 
Corp., Armonk, NY, USA), where a p-value of <0.05 was considered statistically significant. A 
normality test was performed to examine the normality of each data. According to the results, we 
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selected either parametric tests or non-parametric tests to analyze the data to investigate the 
effectiveness of SRP for changing them RNA expression of MMP-9 and the clinical parameters 
before SRP and 1 month afterward. Wilcoxon test was used to analyze CAL and fold-gene 
expression of MMP-9. PD and PBI were analyzed using a paired t-test. 
The correlation analysis of MMP-9 and periodontal clinical parameters from the same site of 
GCF collection was performed at baseline and 1 month after collecting the SRP data. In this study, 
MMP-9 showed an abnormal data distribution; therefore, analyses were performed with the 
Spearman test, considering p<0.05 to be statistically significant. 
 
Ethical Aspects 
This research was approved by the Ethical Committee of the Faculty of Dentistry, 
Universitas Indonesia (Protocol No. 090240218). 
 
Results 
A statistically significant difference was noted in the periodontal clinical parameters between 
baseline and at 1 month of SRP on the 4-6 mm pocket of CP patients. No statistically significant 
difference in MMP-9 was noted between baseline and at 1 month after SRP on the 4-6 mm pocket of 
CP patients. A paired t-test was used to analyze PD and PBI, and the Wilcoxon test was used to 
analyze CAL and MMP-9. The results of these comparative analyses are shown in Table 1. 
Correlation analysis was performed with the Spearman test (Table 2). 
 
Table 1. Distribution of clinical parameters after one month of SRP. 
Variables Mean (SD) Median (Minimum–Maximum) p-value 
 Baseline One Month Baseline One Month  
PD 4.10 (0.10) 3.21 (0.33)   0.002 
PBI 1.12 (0.62) 0.56 (0.48)   0.048 
CAL   2.07 (2.00–5.25) 1.30 (1.00–4.25) 0.024 
MMP-9   1.61 (0.51–99.73) 1.26 (0.19–2.89) 0.463 
*p<0.05 indicate a significant difference. 
 
A weak correlation in the positive direction was revealed on the alteration of MMP-9 with 
the alteration of PBI (Figure 1). 
 
Table 2. Correlational analysis of the alteration of the fold gene expression of MMP-9 with the 
alteration of PD, PBI, and CAL. 
Variables R p-value 
Alteration of MMP-9 – PD -0.030 0.954 
Alteration of MMP-9 – PBI 0.116 0.827 
Alteration of MMP-9 – CAL -0.135 0.798 
*p<0.05 indicate a significant difference 
 
No correlation was noted in the negative direction on the alteration of MMP-9 with the 
alteration of PD and on the alteration of MMP-9 with the alteration of CAL. 
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Figure 1. Correlational diagram between the Alteration of MMP-9 and alteration of PBI at 1 month 
after SRP. 
 
Discussion 
In this study, we found an improvement in the periodontal clinical parameters and reduced 
expression of MMP-9 in GCF after 1month of scaling and root planing in CP patients with 4-6 mm 
pockets. However, the reduced MMP-9 was not statistically significant. Alteration of MMP-9 
expression showed no negative correlation with the alteration of PD and CAL, and a weak 
correlation in the positive direction was noted with the alteration of PBI. 
Cumulatively, our results suggest that SRP succeeded in treating CP with 4-6 mm pockets, 
in accordance with the previous findings [12]. Thus, periodontal clinical parameters are essential in 
diagnosing periodontal tissue destruction, and PBI is more correlated with periodontal disease 
activity. To evaluate the activity of periodontal diseases or predict future prognosis, investigation of 
the inflammatory molecule level was considered [13]. 
MMPs contribute to both normal and pathological tissue remodeling. The physiological 
roles of MMPs include cell migration, tissue remodeling during organogenesis and growth, wound 
healing, angiogenesis, enamel formation, and antigen processing and presentation. These roles are 
strongly correlated to periodontal diseases since MMPs are the major players in collagen breakdown 
during periodontal tissue destruction. Gelatinases (MMP-2,-9) degrade the denaturated collagen 
gelatin [4]. 
The presence of MMP in oral fluids provides additional information about disease 
progression. Oral fluid samples were used to investigate MMP and their regulators as potential 
candidates in chair-side tests for monitoring periodontal and peri-implant diseases. For estimating 
the level of MMP, samples can be collected from the saliva, GCF, and tissues [5]. A previous study 
found that the analysis of the MMP-9group in the saliva before and after SRP was not a precise 
indicator of periodontal disease using the zymographic assay [6]. Several studies have suggested 
that MMP-9 in GCFhas a higher concentration following a severe inflammation [5]. Here, no 
statistically significant reduction of MMP-9 was noted at 1 month of SRP. Our findings are in line 
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with those of past studies that showed decreased MMP-9 levels in non-surgical therapy. Some 
authors reported decreased MMP-9 in GCF (over three months) and circulating blood after non-
surgical treatment [7,14.], while others reported increased MMP-9 during a periodontal disease, 
which effectively reduced with non-surgical therapy [4]. 
MMPs as inflammatory molecules released from different cell types (e.g., macrophages, 
leukocytes, fibroblast, and other resident cells) in a lesion play a direct role in the degradation of 
both non-mineralized and mineralized tissues of the periodontium. MMP is produced at low levels or 
not at all in resting-state adult tissues [5]. A good body of evidence suggests that MMP-9is 
essential in bone resorption for osteoclast to access the resorption site, and it has been recently 
considered as important for osteoblast in bone development and formation [4]. The alteration of 
MMP-9 is weakly correlated in the positive direction with the alteration of PBI; this result may be 
attributed to ongoing inflammatory activities. Regarding the evidence of MMP’s role in the 
periodontal destruction process, the study of MMP may provide information about whether, in the 
future, it will be important to use a host modulatory agent such as an MMP inhibitor in adjunctive 
therapy combined with conventional treatment. 
 
Conclusion 
Scaling and root planing is clinically effective for chronic periodontitis patients with 4-6-mm 
pockets, despite no statistically significant result of MMP-9 mRNA expression in the gingival 
crevicular fluid after 1 month of scaling and root planing. The weak correlation between MMP-9 and 
Papilla Bleeding Index may be attributed to ongoing inflammatory activities. Further studies with a 
longer observation period are needed to confirm or reject the above findings. 
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